Literature DB >> 9515206

Macrophages and tuberculosis.

M J Fenton1.   

Abstract

Almost one third of the world's population is infected with Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis. Each year there are eight million new cases of tuberculosis and three million deaths from the disease worldwide. Mtb is an intracellular pathogen that resides predominantly within macrophages. Paradoxically, macrophages also represent the first line of defense against this pathogen. Significant recent advances have been made in understanding the mechanisms by which Mtb gains entry into the macrophage, suppresses the microbicidal activities of this host cell, and ultimately subverts cell-mediated immune responses that eradicate the infection. This article reviews recent findings that contribute to our understanding of the roles played by mononuclear phagocytes in the immune response against tuberculosis.

Entities:  

Mesh:

Year:  1998        PMID: 9515206     DOI: 10.1097/00062752-199801000-00012

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  14 in total

Review 1.  The presence of 3-hydroxy oxylipins in pathogenic microbes.

Authors:  Olihile M Sebolai; Carolina H Pohl; Lodewyk J F Kock; Vishnu Chaturvedi; Maurizio del Poeta
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-11-11       Impact factor: 3.072

2.  Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages.

Authors:  Stewart T Chang; Jennifer J Linderman; Denise E Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

3.  Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth.

Authors:  Jussi J Saukkonen; Beth Bazydlo; Michael Thomas; Robert M Strieter; Joseph Keane; Hardy Kornfeld
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Induction of macrophage-derived SLPI by Mycobacterium tuberculosis depends on TLR2 but not MyD88.

Authors:  Aihao Ding; Hongwei Yu; Jingxuan Yang; Shuangping Shi; Sabine Ehrt
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

5.  Individual Mycobacterium tuberculosis universal stress protein homologues are dispensable in vitro.

Authors:  S M Hingley-Wilson; K E A Lougheed; K Ferguson; S Leiva; H D Williams
Journal:  Tuberculosis (Edinb)       Date:  2010-06-11       Impact factor: 3.131

Review 6.  HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages.

Authors:  Bruce D Freedman; Qing-Hua Liu; Manuela Del Corno; Ronald G Collman
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection.

Authors:  Patricia Fontán; Virginie Aris; Saleena Ghanny; Patricia Soteropoulos; Issar Smith
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

8.  Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan.

Authors:  Junji Uehori; Misako Matsumoto; Shoutaro Tsuji; Takashi Akazawa; Osamu Takeuchi; Shizuo Akira; Tsutomu Kawata; Ichiro Azuma; Kumao Toyoshima; Tsukasa Seya
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Role of Pre-A motif in nitric oxide scavenging by truncated hemoglobin, HbN, of Mycobacterium tuberculosis.

Authors:  Amrita Lama; Sudesh Pawaria; Axel Bidon-Chanal; Arvind Anand; José Luis Gelpí; Swati Arya; Marcelo Martí; Dario A Estrin; F Javier Luque; Kanak L Dikshit
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

10.  Mycobacterium tuberculosis-induced expression of granulocyte-macrophage colony stimulating factor is mediated by PI3-K/MEK1/p38 MAPK signaling pathway.

Authors:  Jang-Eun Cho; Sangjung Park; Hyeyoung Lee; Sang-Nae Cho; Yoon Suk Kim
Journal:  BMB Rep       Date:  2013-04       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.